MXPA05010104A - Polvo cristalino de trihidrato de amoxicilina. - Google Patents

Polvo cristalino de trihidrato de amoxicilina.

Info

Publication number
MXPA05010104A
MXPA05010104A MXPA05010104A MXPA05010104A MXPA05010104A MX PA05010104 A MXPA05010104 A MX PA05010104A MX PA05010104 A MXPA05010104 A MX PA05010104A MX PA05010104 A MXPA05010104 A MX PA05010104A MX PA05010104 A MXPA05010104 A MX PA05010104A
Authority
MX
Mexico
Prior art keywords
amoxicillin trihydrate
crystalline
powder
trihydrate powder
crystalline amoxicillin
Prior art date
Application number
MXPA05010104A
Other languages
English (en)
Inventor
Johannus Anthonius M Everardus
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45007138&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA05010104(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of MXPA05010104A publication Critical patent/MXPA05010104A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La invencion se refiere a un polvo cristalino de trihidrato de amoxicilina con una densidad aparente mayor de 0.45g/ml. La invencion se refiere tambien a un proceso para preparar polvo cristalino de trihidrato de amoxicilina, donde dicho proceso comprende: cristalizar el trihidrato de amoxicilina desde una solucion que contiene amoxicilina disuelta; separar los cristales de dicha solucion; y secar los cristales separados, para dar un polvo cristalino con una densidad aparente mayor de 0.45g/ml.
MXPA05010104A 2003-03-21 2004-03-19 Polvo cristalino de trihidrato de amoxicilina. MXPA05010104A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US45618703P 2003-03-21 2003-03-21
US45618803P 2003-03-21 2003-03-21
EP03100732 2003-03-21
EP03100731 2003-03-21
PCT/EP2004/002989 WO2004082661A1 (en) 2003-03-21 2004-03-19 Crystalline amoxicillin trihydrate powder

Publications (1)

Publication Number Publication Date
MXPA05010104A true MXPA05010104A (es) 2005-11-23

Family

ID=45007138

Family Applications (2)

Application Number Title Priority Date Filing Date
MXPA05010102A MXPA05010102A (es) 2003-03-21 2004-03-19 Trihidrato de amoxicilina.
MXPA05010104A MXPA05010104A (es) 2003-03-21 2004-03-19 Polvo cristalino de trihidrato de amoxicilina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MXPA05010102A MXPA05010102A (es) 2003-03-21 2004-03-19 Trihidrato de amoxicilina.

Country Status (14)

Country Link
US (1) US20060172987A1 (es)
EP (2) EP1808166A1 (es)
JP (2) JP4949827B2 (es)
CN (2) CN102260278B (es)
AT (1) ATE362359T1 (es)
BR (2) BRPI0408403A (es)
CY (1) CY1106809T1 (es)
DE (1) DE602004006507T2 (es)
ES (1) ES2286627T3 (es)
MX (2) MXPA05010102A (es)
PL (1) PL1610766T3 (es)
PT (1) PT1610766E (es)
SI (1) SI1610766T1 (es)
WO (3) WO2004082662A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408403A (pt) * 2003-03-21 2006-03-21 Dsm Ip Assets Bv pó cristalino de triidrato de amoxicilina
US7534781B2 (en) * 2003-03-21 2009-05-19 Dsm Ip Assets B.V. Crystalline amoxicillin trihydrate powder
AU2008254037B2 (en) * 2007-05-21 2013-10-17 Toray Industries, Inc. Crystalline micropowder particles
US7985791B1 (en) 2008-02-22 2011-07-26 Lords Additives LLC Incorporation of SBP and ulexite into composites
EP2778171A1 (en) * 2013-03-15 2014-09-17 Synbias Pharma Ltd. Crystalline monohydrate of epirubicin hydrochloride
CN103145733B (zh) * 2013-03-20 2014-02-26 四川省惠达药业有限公司 一种阿莫西林化合物及该化合物和克拉维酸钾的药物组合物
EP3041845A1 (en) * 2013-09-03 2016-07-13 DSM Sinochem Pharmaceuticals Netherlands B.V. Micronized amoxicillin
CN104059086B (zh) * 2014-06-19 2016-04-13 河南牧翔动物药业有限公司 一种阿莫西林晶体及其制备方法
CN104099396B (zh) * 2014-07-22 2016-03-23 石药集团中诺药业（石家庄）有限公司 一种直通法制备阿莫西林的工艺
WO2017186864A1 (en) 2016-04-27 2017-11-02 Sandoz Ag Enzymatic process for the production of beta-lactam antibiotics in the presence of particulate inoculum
CN109867687B (zh) * 2017-12-05 2021-08-17 上海朝瑞化工有限公司 一种高水溶性阿莫西林及其制备方法
CN111518119B (zh) * 2020-05-26 2021-12-21 联邦制药(内蒙古)有限公司 一种阿莫西林连续结晶工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532672A (en) * 1976-07-20 1978-11-15 Bristol Myers Co Process for the preparation of amoxicillin trihydrate
JPS5583789A (en) * 1978-12-18 1980-06-24 Bristol Myers Co Preparation of penicillin
JPS6052751B2 (ja) * 1981-04-21 1985-11-21 富山化学工業株式会社 新規な結晶形を有するセフアレキシン１水和物
AU6106794A (en) * 1993-02-15 1994-08-29 Gist-Brocades N.V. An improved beta -lactam antibiotic composition
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
CN1268888A (zh) * 1997-08-29 2000-10-04 Dsm公司 不含赋形剂的颗粒
US20020137926A1 (en) * 1998-06-01 2002-09-26 Smithkline Beecham Corporation Process for preparing crystalline salts of amoxycillin
WO2000041478A2 (en) * 1999-04-01 2000-07-20 Dsm N.V. Agglomerates by crystallisation
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
BRPI0408403A (pt) * 2003-03-21 2006-03-21 Dsm Ip Assets Bv pó cristalino de triidrato de amoxicilina

Also Published As

Publication number Publication date
MXPA05010102A (es) 2005-11-23
PL1610766T3 (pl) 2007-08-31
EP1610766A1 (en) 2006-01-04
CN1761457A (zh) 2006-04-19
WO2004082663A1 (en) 2004-09-30
BRPI0408403A (pt) 2006-03-21
EP1808166A1 (en) 2007-07-18
US20060172987A1 (en) 2006-08-03
JP2006520765A (ja) 2006-09-14
JP4949826B2 (ja) 2012-06-13
JP4949827B2 (ja) 2012-06-13
SI1610766T1 (sl) 2007-10-31
DE602004006507T2 (de) 2008-01-31
PT1610766E (pt) 2007-08-01
CY1106809T1 (el) 2012-05-23
ES2286627T3 (es) 2007-12-01
CN102260278A (zh) 2011-11-30
BRPI0408568A (pt) 2006-03-21
ATE362359T1 (de) 2007-06-15
EP1610766B1 (en) 2007-05-16
CN1761457B (zh) 2010-05-12
DE602004006507D1 (en) 2007-06-28
CN102260278B (zh) 2015-05-06
WO2004082661A1 (en) 2004-09-30
JP2006523188A (ja) 2006-10-12
WO2004082662A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
MXPA05010104A (es) Polvo cristalino de trihidrato de amoxicilina.
MXPA02003122A (es) Acidos indolalcanoicos substituidos.
HUP0400927A3 (en) New crystalline form and pure modafinil, process of preparing them, and pharmaceutical compositions containing the new crystalline form
HUP0301802A3 (en) Process for producing carvedilol, crystalline carvedilol, process for producing it and pharmaceutical composition containing it
HUP0200076A3 (en) C-21 modified epothilones, process for their preparation, pharmaceutical compositions containing them
GB0016040D0 (en) Novel process for preparing crystalline particles
EP1488790A4 (en) SOLID PREPARATION CONTAINING A MONOCRYSTALLINE FORM
HK1090042A1 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the of the same as medicaments, and medicament containing such compounds
JO3360B1 (ar) الشكل البلوري الجديد 3 للأغوميلاتين وعملية تحضيره والمكونات الصيدلانية التي تحتويه
TW200605917A (en) Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation
PL371339A1 (en) Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations
HK1054026A1 (en) Substituted piperidines, medicaments containing these compounds, and methods for the production thereof.
MX230696B (es) 5-cloro-3-(4-metansulfonilfenil)-6'-metil-[2,3]-bipiridinilo en forma cristalina pura, y procedimiento para su sintesis.
HK1086008A1 (en) Process for preparing substituted 5-amino-pyrazolo-Ä4,3-eÜ-1,2,4-triazoloÄ1,5-cÜpyrimidines
HUP0402391A3 (en) Crystalline sodium salt of telmisartan, process for its production and pharmaceutical compositions containing it
DE60137823D1 (de) Verfahren zur Herstellung von kristallinen Maltitolpartikeln
GB0016002D0 (en) Novel process for preparing crystalline particles
GB2386817A8 (en) Feed for fish containing cysteamine
EP1539718A4 (en) 1,2,4-TRIAZOL DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
HUP0105116A3 (en) 2,3-0-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors, pharmaceutical compositions containing them, process for preparation of the compounds
EP1207150A4 (en) LONG N-EPSILON CHAIN ACYLLYSIN CRYSTALS, PROCESS FOR PRODUCING THE SAME AND COSMETIC PRODUCTS COMPRISING THESE CRYSTALS
AU2002327262A1 (en) A feed additive of nanometer size, a process preparing the same and a feed containing the feed additive of nanometer size
ZA200002674B (en) Process for the synthesis of finely divided antiperspirant active ingredient suspensions.
EP1132383A4 (en) NEW AGAROFURAN DERIVATIVES, THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE AS MEDICINE
EP1571144A4 (en) HYDROXYALKYLATED CYCLIC DEDIAMINE COMPOUND

Legal Events

Date Code Title Description
FG Grant or registration